Parkev Tatevosian, CFA 对 $PFE 的判断变化

频道资料 →频道引用的来源:Barclays analyst Dan Levy、Meta management and CEO Mark Zuckerberg、Nike management共 1 条

Parkev Tatevosian, CFA 自 2026-09-17 起在 1 个视频里谈过 $PFE,最近一次(2026-09-17)为看涨。

2026-09-17看涨
《Is Pfizer an Excellent Dividend Stock to Buy? | PFE Stock Analysis》
AI 摘要 · 辉瑞值得买入;现金流折现模型给出的合理价值为50美元,意味着较当前水平有显著上行空间。

辉瑞的管理层已经在运用人工智能来帮助加速药物研发,这是我在人工智能领域看到的最大看涨机会之一,即它能为全人类带来的总机会价值。

Pfizer's management team is already incorporating artificial intelligence to help accelerate drug discovery, which is one of the biggest bullish opportunities that I see with artificial intelligence in the total opportunity value it can add to humanity worldwide.

他们也在利用人工智能来帮助优化生产良率,并提升其商业销售团队的有效性,但我认为对于这些制药公司来说,更大的机会在于药物研发。

They're also using artificial intelligence to help optimize manufacturing yields and enhance the effectiveness of its commercial sales force, but I think the bigger opportunity is in drug discovery with these pharmaceutical companies.